J9289 Insurance Policy Changes

HCPCS J9289 is officially defined as "Injection, nivolumab, 2 mg and hyaluronidase-nvhy." HCPCS J9289 is referenced in 2 tracked payer policy changes from Michigan Medicaid - MDHHS and Blue Cross Blue Shield of Rhode Island. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J9289 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Only a small number of policies match this filter. Check back as coverage expands.

Related

All billing codes992129920299203992139920499214

Get alerts for changes like this

Save a search and receive a daily digest whenever a new policy change matches your filters.

Create a free alert